Target intelligence / Profile preview

Double plant homeodomain finger 2 (DPF2)

Target
DPF2
Molecular classification
Transcription factor, Chromatin regulator, Histone modification "reader", Zinc finger protein, SWI/SNF complex component
01

Overview

Double plant homeodomain finger 2 (DPF2) is a highly conserved transcription factor and chromatin regulator that contains a C2H2-type zinc finger domain and tandem plant homeodomain (PHD) finger motifs, enabling it to bind to and “read” specific acetylation and crotonylation marks on histones H3 and H4[1][2][3][4]. Through these interactions, DPF2 integrates into multi-protein complexes, notably the SWI/SNF chromatin remodeling complex, and modulates the transcription of target genes—often repressing myeloid differentiation by forming repressive complexes on specific promoters (such as miR-223) and regulating pathways such as non-canonical NF-κB signaling[1][2][3][4]. DPF2 is implicated in the pathogenesis of hematological malignancies (such as leukemia), development of lymphoid cells, and rare congenital syndromes like Coffin-Siris syndrome 7[1][3][4].

Other names
Zinc finger protein ubi-d4BAF45DREQUBID4SMARCG2Apoptosis response zinc finger proteinBRG1-associated factor 45DD4protein requiemCoffin-Siris syndrome 7 protein
02

Biological functions

Transcriptional regulationChromatin remodelingMyeloid cell differentiation inhibitionApoptosis regulationImmune response modulation (e.g., interferon signaling)
03

Disease associations

Cancer (notably acute myeloid leukemia and potentially multiple endocrine neoplasia type I)Coffin-Siris syndrome 7Hematologic malignanciesOther disorders with aberrant cell differentiation or proliferation
04

Safety considerations

Potential for hematopoietic toxicity if inhibited (due to role in stem/progenitor differentiation)Broad role in transcription and chromatin regulation may predispose to off-target effects if targeted therapeutically

Beyond the preview

Go deeper on Double plant homeodomain finger 2 (DPF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double plant homeodomain finger 2 (DPF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call